Avid plans expansion with focus on biologics development
There is no slowdown in sight, says Avid Bioservices CEO, as the company today announces further expansion to support new client projects and optimize its novel CHO-based expression system.
Archives for April 24, 2018
US FDA halts approval for Pfizer’s trastuzumab biosimilar
The US FDA has issued Pfizer a complete response letter for its proposed biosimilar version of Roche’s cancer drug Herceptin.
INTERPHEX 2018
MilliporeSigma looks beyond ‘burn and bury’ for single-use recycling
MilliporeSigma is urging industry to recycle single-use technologies, which can be made into speed pumps, parking bollards, and plastic palettes.